drugset
drugset / Trial / NCT04560465

Efficacy of Tranexamic Acid in Reducing Myomectomy Associated Blood Loss in Federal Teaching Hospital Abakaliki.

NCT04560465 ↗

Phase 2 Completed 59 enrolled Alex Ekwueme Federal University Teaching Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

to determine safety and efficacy of Tranexamic Acid in reducing blood loss during Myomectomy in our institution.

Timeline

Start
2018-06-01
Primary completion
2019-05-31
Completion
2019-06-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 1000 mg Intravenous

Indications

No indication recorded.